---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-025258"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2022-09-07T23:59:59+00:00"
generated_at: "2026-06-23T13:41:05.995107+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals appoints Kirko Kirkov as Chief Commercial Officer effective Sept. 6, 2022

## Summary
- Base salary $150k/year; increases to $275k after one year contingent on corporate goals.
- Eligible for annual bonus up to 50% of salary (20% personal KPIs, 30% corporate performance).
- Upon board approval, granted options to purchase 3,000,000 shares vesting over 3 years.
- Kirkov brings 20+ years experience, most recently General Manager at Vertice Pharma.
- New position to oversee sales and marketing of commercial products under Elite label.

## SEC filing metadata
- accession: 0001493152-22-025258
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2022-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/0001493152-22-025258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-025258
- JSON: https://secwatch.observer/filing/0001493152-22-025258.json
- Plain text: https://secwatch.observer/filing/0001493152-22-025258.txt

## Key facts
- Executive change
  Kirko Kirkov was appointed as Chief Commercial Officer at ELITE PHARMACEUTICALS INC /NV/.
  - Action: appointed
  - Role: Chief Commercial Officer
  source text: On September 5, 2022, Elite Pharmaceuticals, Inc., a Nevada corporation (the “Registrant”), entered into an employment agreement with Kirko Kirkov to serve as the Registrants’ Chief Commercial Officer effective September 6, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/0001493152-22-025258-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.